ArticleCancers2026

Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery.

Jeeyeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.